Thanks to all the brilliant scientists for this talk and for spreading the knowledge. i have a question please : does the WHO/ICC 2022 update mean that we will need from now on, to be performing cytogenetics/molecular biology , searching for recurrent AML abnomalies , systematically on all bone marrow samples ?